Akèy › Obèsite › New York › New York City
Etid klinik pou Obèsite nan New York City, NY
40 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
The RESET System Pivotal Clinical Trial (Protocol Revision H)
Ap rekrite
- Weill Cornell Medicine, New York
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Ap rekrite
- Weill Cornell -1300 York Avenue, New York
- Lenox Hill Hospital | Northwell Health, New York
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
- Weill Cornell Medicine - Comprehensive Weight Control Center, New York
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Ap rekriteFaz 2
- ALSA Research-Manhattan, New York
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Ap rekriteFaz 3
- Comprehensive Weight Ctrl Prog, New York
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Ap rekriteFaz 3
- New York Gastroenterology Associates, New York
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Ap rekriteFaz 3
- New York Gastroenterology Associates, New York
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ap rekriteFaz 3
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Ap rekriteFaz 3
- NYU Langone Health, New York
- Weill Cornell Medical College, New York
- IMA Clinical Research Manhattan, New York
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- Icahn School of Medicine at Mount Sinai, New York
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- Weil Cornell Medicine, New York
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- Weil Cornell Medicine, New York
Graded Insulin Suppression Test P&F
Ap rekriteFaz 1Volontè an sante akeyi
- Columbia University Irving Medical Center, New York
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
- Equity Medical, New York
- Care Access - Hoboken, Hoboken · 2 mi lwen
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, New York
Alpelisib Challenge Test (ACT)
Ap rekriteFaz 1Volontè an sante akeyi
- Columbia University Irving Medical Center, New York
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
Ap rekriteFaz 2Volontè an sante akeyi
- Mexican Consulate's Ventanilla de Salud (VDS), New York
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Icahn School of Medicine at Mount Sinai, New York
Incretin Therapies in Obesity-related HFpEF
Ap rekriteFaz 4
- Columbia University Irving Medical Center (CUIMC) / NewYork Presbyterian Hospital (NYP), New York
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Ap rekriteFaz 1Volontè an sante akeyi
- Columbia University Irving Medical Center, New York
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ap rekriteFaz 3
- NYU Langone Med Assoc Chelsea, New York
- NYU Langone Orthopedic Center, New York
- Mount Sinai Hosp at NYC, New York
- ak 1 plis
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Ap rekriteFaz 3
- NYU Langone Orthopedic Center, New York
- Hospital For Special Surgery, New York
Atomoxetine in Melanocortin Obesity Syndrome
Ap rekriteFaz 2
- Mount Sinai Hospital, New York
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Ap rekriteFaz 4
- Weill Cornell Medicine, New York
Effect of Insulin Lowering on Lipogenesis
Ap rekriteFaz 1
- Columbia University Irving Medical Center, New York
A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program
Ap rekrite
- Columbia University Irving Medical Center, New York
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
Ap rekriteFaz 4
- Columbia University Medical Center, New York
Impact of Yo-Yo Sleep on Cardiometabolic Health
Ap rekriteVolontè an sante akeyi
- Columbia University Irving Medical Center, New York
Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
Ap rekriteEtid obsèvasyon
- Weill Cornell Medicine, New York
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Ap rekriteFaz 3Volontè an sante akeyi
- Vanda Investigational Site, New York
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
Ap rekriteVolontè an sante akeyi
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Ap rekriteFaz 1 bonè
- Memorial Sloan Kettering Cancer Center, New York
Reducing Obesity Using Social Ties Program
Ap rekrite
- Weill Cornell Medicine, New York
CHIME: Comparing Health Interventions for Maternal Equity
Ap rekriteVolontè an sante akeyi
- Columbia University Medical Center, New York
- NYU Langone Health, New York
Time Restricted Eating for WeIght LoSs MainTenance-2
Ap rekrite
- NYU Langone Health, New York
High Fructose Diet, the Gut Microbiome, and Metabolic Health
Ap rekriteVolontè an sante akeyi
- Mount Sinai Morningside, New York
Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.
Ap rekriteEtid obsèvasyon
- Columbia University Medical Center, New York
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Ap rekrite
- Columbia University Medical Center, New York
Effects of Ultra Processed Food on Intestinal Energy Harvest
Ap rekrite
- Columbia University Irving Medical Center, New York
Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults
Ap rekriteEtid obsèvasyon
- NYU Steinhardt Arthur J. Nelson Laboratory, New York
- New York City Health + Hospitals/Bellevue Hospital, New York
- NYU CTSI Clinical Research Center, New York
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL32 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD26 etid
- Jacksonville, FL25 etid
- St. Louis, MO25 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.